ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Laboratories launches generic version of fesoterodine fumarate tablets in US
The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added. Citing IQVIA data, Dr Reddy's said the Toviaz brand had
Announcement as on 08 July 2022

Dr Reddy's Lab says its Andhra plant gets two observations from USFDA
Dr Reddy's Laboratories Ltd on Thursday said the US health regulator has issued Form 483 with two observations after inspecting its manufacturing facility located at Srikakulam in Andhra Pradesh. As per USFDA, Form 483 is issued to a firm's management at t
Announcement as on 07 July 2022

Dr Reddy's Laboratories says its Andhra plant gets two observations from USFDA
The US Food and Drug Administration (USFDA) completed a pre-approval inspection at the company's formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh on Thursday, Dr Reddy's said in a regulatory filing. The inspection was conducted from
Announcement as on 07 July 2022

Dr Reddy's says it aims to triple reach to 1.5 bn patients by 2030
Under its sustainability goals for the next decade, Dr Reddy's said it is making its "products accessible and affordable for patients" and "25 per cent of new launches to be first to market by 2027"
Announcement as on 06 July 2022

JB Pharma acquires paediatric brands from Dr Reddy's for Rs 98.3 crore
The four brands are zinc supplement Z&D, insomnia medication Pedicloryl, antibiotic Pecef and Ezinapi, which is used against diaper rashes. The four brands combined had sales of Rs 33 crore in the fiscal year ended March 31, 2022.
Announcement as on 01 July 2022

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.77
  • 12Day Average: 13.53
  • 20Day Average: 13.93
  • 50Day Average: 13.58
  • 100Day Average: 13.66
  • 150Day Average: 13.73
  • 200Day Average: 13.8

RDY Indicators & signals

Indicator MACD (12,26,9)

13.32, 13.58, -0.04
Indicator MACD is in negative zone

Indicator ADX (14)

39.13, 18.42, 42.11
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Fri Jul 2026 12.60 12.57 to 12.84 -0.79% 0.49 times
16 Thu Jul 2026 12.70 12.66 to 12.85 -0.55% 0.66 times
15 Wed Jul 2026 12.77 12.75 to 12.95 -0.55% 0.73 times
14 Tue Jul 2026 12.84 12.70 to 12.95 -0.62% 0.99 times
13 Mon Jul 2026 12.92 12.92 to 13.27 -2.12% 0.85 times
10 Fri Jul 2026 13.20 13.06 to 13.70 -4.97% 1.02 times
09 Thu Jul 2026 13.89 13.57 to 14.06 -1.63% 1.82 times
08 Wed Jul 2026 14.12 13.85 to 14.59 -3.49% 1.54 times
07 Tue Jul 2026 14.63 14.34 to 14.72 1.88% 1.08 times
06 Mon Jul 2026 14.36 14.23 to 14.38 -0.14% 0.47 times
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.85 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 1.4 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top